W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind. Earlier diagnosis would mean that people could take advantage of the drugs sooner, when the medicines are most effective.

Researchers from Washington University School of Medicine and Lund University have identified a highly accurate blood test that can both diagnose and asses